| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.5M | -1.9% | +44.6% |
| Cost of Revenue | $2.9M | -6.3% | +69.8% |
| Gross Profit | $1.07B | — | — |
| R&D Expense | $59K | +7.3% | -66.3% |
| SG&A Expense | $2.1M | +76.4% | +93.6% |
| Operating Income | -$2.6M | -90.7% | -122.0% |
| Pre-tax Income | -$1.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.6M | — | +5717.9% |
| Accounts Receivable | $2.4M | +31.1% | +51.6% |
| Current Assets | $7.9M | -10.4% | +345.2% |
| Total Assets | $13.8M | -5.0% | +190.3% |
| Current Liabilities | $3.9M | +23.8% | -35.7% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.7M | — | — |
| Capital Expenditures | $6K | — | — |
| Investing Cash Flow | -$1.3M | — | — |
| Financing Cash Flow | $12.6M | — | — |
| Free Cash Flow | -$9.7M | — | — |
| -52.8% |
| Income Tax | $2K | — | +0.0% |
| Net Income | -$1.9M | -39.3% | -52.6% |
| EPS (Basic) | -$0.42 | +27.6% | -90.9% |
| EPS (Diluted) | -$0.42 | +27.6% | -90.9% |
| $5.1M |
| +17.3% |
| -22.4% |
| Stockholders' Equity | $8.7M | -14.5% | +580.0% |